aspartic acid has been researched along with sildenafil citrate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campolo, F; Gevi, F; Naro, F; Zolla, L | 1 |
| Anstrom, K; Bain, JR; Felker, GM; Hernandez, A; Ilkayeva, O; Kraus, WE; McNulty, S; Muehlbauer, MJ; Newgard, CB; Redfield, M; Shah, SH; Wang, H | 1 |
2 other study(ies) available for aspartic acid and sildenafil citrate
| Article | Year |
|---|---|
The cardioprotective effect of sildenafil is mediated by the activation of malate dehydrogenase and an increase in the malate-aspartate shuttle in cardiomyocytes.
Topics: Animals; Aspartic Acid; Benzophenanthridines; Cardiotonic Agents; Cell Line, Tumor; Citric Acid Cycle; Cyclic GMP-Dependent Protein Kinases; Enzyme Activation; Fluoresceins; Glucose; Glycolysis; Malate Dehydrogenase; Malates; Mice; Myocytes, Cardiac; Pentose Phosphate Pathway; Peptide Fragments; Protein Kinase C; Sildenafil Citrate | 2017 |
Sildenafil Treatment in Heart Failure With Preserved Ejection Fraction: Targeted Metabolomic Profiling in the RELAX Trial.
Topics: Aged; Asparagine; Aspartic Acid; Biomarkers; Carnitine; Female; Heart Failure; Humans; Male; Metabolomics; Middle Aged; Phosphodiesterase 5 Inhibitors; Sildenafil Citrate; Stroke Volume | 2017 |